Pharmacogenomics (journal)

Pharmacogenomics is a peer-reviewed medical journal established in 2000 and published by Future Medicine. The editors-in-chief are David Gurwitz (Tel-Aviv University), Howard McLeod (University of North Carolina at Chapel Hill), and Munir Pirmohamed (University of Liverpool). The journal covers the field of pharmacogenomics.

Pharmacogenomics
DisciplinePharmacogenomics
LanguageEnglish
Edited byDavid Gurwitz, Howard McLeod, Munir Pirmohamed
Publication details
History2000–present
Publisher
Future Medicine Ltd
Frequency18/year
2.350 (2016)
Standard abbreviations
ISO 4Pharmacogenomics
Indexing
CODENPARMFL
ISSN1462-2416 (print)
1744-8042 (web)
OCLC no.55059877
Links

Abstracting and indexing

The journal is abstracted and indexed in Biological Abstracts, BIOSIS Previews, Biotechnology Citation Index, Chemical Abstracts, Current Contents/Life Sciences, EMBASE/Excerpta Medica, Index Medicus/MEDLINE/PubMed, Science Citation Index, and Scopus. According to the Journal Citation Reports, the journal has a 2016 impact factor of 2.350, ranking it 132nd out of 256 journals in the category "Pharmacology & Pharmacy".[1]

gollark: ?remind 9999y bee
gollark: ?remind 999y bee.
gollark: I think they can go up to 9999 years?
gollark: I could link it on osmarks.tk™, osmarks.tk™ is highly popularity?
gollark: Maybe I could steal (with attribution, in accordance with what I assume are open source licenses on them) some js13kgames entries.

References

  1. "Journals Ranked by Impact: Pharmacology & Pharmacy". 2016 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2017.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.